PETAL: A Global T-Cell Lymphoma Consortium
Integration of machine learning and genomics to predict outcomes for newly diagnosed, relapsed, and refractory mature T-cell and NK-cell neoplasms.
Learn More

Who we are

Led by Massachusetts General Hospital Cancer Center, we are a collaborative network of global T-cell lymphoma investigators, lymphoma professionals, biostatisticians, researchers, and bioinformaticians who are passionate about scientific discoveries and technological innovations to enhance outcomes for T-cell lymphomas with the use of genomics and artificial intelligence approaches to make personalized survival predictions.

Learn More

What we do